TRINITY BIOTECH PLC-SPON ADR (TRIB)
US8964385046 - ADR
TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023
TRIB stock results show that Trinity Biotech missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
TRIB Stock Earnings: Trinity Biotech Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trinity Biotech (NASDAQ:TRIB) just reported results for the fourth quarter of 2...
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes...
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results
Conference Call Scheduled for Thursday, April 4, 2024 at 8:00 AM ET...
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal...
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective...
Trinity Biotech to implement ADS ratio change (NASDAQ:TRIB)
Trinity Biotech plans to change its ADS ratio, enabling compliance with Nasdaq's minimum bid price requirement and affecting ADS trading on February 21.
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio...
Trinity Biotech to Present at Emerging Growth Conference
DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present...
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Trinity Biotech partners with Bayer to launch CGM device in China and India (NASDAQ:TRIB)
Trinity Biotech announces a non-binding letter of intent with Bayer to launch Continuous Glucose Monitoring devices in China and India.
Trinity Biotech Announces Q3 2023 Financial Results & Business Update
-Investor call to be held today at 8:30 am EST...
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a...
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new...
Trinity Biotech plc to Host Investor Call
Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET...
Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya
DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic...
Trinity Biotech promotes finance chief John Gillard to CEO (NASDAQ:TRIB)
Trinity Biotech promotes CFO John Gillard to CEO; Aris Kekedjian steps down as board member. Des Fitzgerald appointed interim CFO.
Trinity Biotech Announces Management Changes
John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) --...
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic...
Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health
DUBLIN, Ireland, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic...
Trinity Biotech Announces Q2 2023 Financial Results
DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results
Conference Call Scheduled for October 3, 2023 at 11:00 am EASTERN...